MXCT Stock Analysis: Buy, Sell, or Hold?
MXCT - MaxCyte, Inc. Common Stock
$0.91
-0.07 (-7.54%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 10, 2026
Get Alerted When MXCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MXCT this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MXCT is down 21.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MXCT is down 21.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MXCT is currently trading at $0.91, which is considered oversold relative to its 30-day fair value range of $1.14 to $1.56.
Technical Outlook: Technically, MXCT is in a strong downtrend. The price is currently testing key support at $0.94. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.24 (+638.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MXCT is in a strong downtrend. The price is currently testing key support at $0.94. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.24 (+638.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.14 -
$1.56
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding MXCT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.5%)
- BULLISH: Trading 638.2% below Wall St target ($7.24)
- WARNING: Recommendation downgraded due to -21.8% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.14 -
$1.56
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.94
Resistance Level
$1.31
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.37
Wall Street Target
$7.24
(+638.2%)
Revenue Growth (YoY)
-16.4%
Profit Margin
-132.6%
Last updated: January 31, 2026 1:18 AM ET
Data refreshes hourly during market hours. Next update: 2:18 AM
Data refreshes hourly during market hours. Next update: 2:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MXCT showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Douglas J Swirsky
BUY
50000 shares
2025-08-13
Maher Masoud
BUY
75000 shares
2025-08-13
Richard Douglas
BUY
80000 shares
2025-08-13
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced MXCT Option Strategies
Professional options setups generated by AI based on today's MXCT price and gamma walls.
